These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 27528454)
1. The appropriateness and persistence of testosterone replacement therapy in Ontario. Martins D; Yao Z; Tadrous M; Shah BR; Juurlink DN; Mamdani MM; Gomes T; Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):119-126. PubMed ID: 27528454 [TBL] [Abstract][Full Text] [Related]
2. Long-term treatment patterns of testosterone replacement medications. Donatucci C; Cui Z; Fang Y; Muram D J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541 [TBL] [Abstract][Full Text] [Related]
3. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism. Smith RP; Khanna A; Coward RM; Rajanahally S; Kovac JR; Gonzales MA; Lipshultz LI J Sex Med; 2013 Sep; 10(9):2326-33. PubMed ID: 23859250 [TBL] [Abstract][Full Text] [Related]
4. Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study. Tadrous M; Martins D; Lee K; Knowles S; Mamdani MM; Juurlink DN; Gomes T Expert Rev Pharmacoecon Outcomes Res; 2016 Dec; 16(6):803-807. PubMed ID: 26986676 [TBL] [Abstract][Full Text] [Related]
5. Medication adherence and treatment patterns for hypogonadal patients treated with topical testosterone therapy: a retrospective medical claims analysis. Schoenfeld MJ; Shortridge E; Cui Z; Muram D J Sex Med; 2013 May; 10(5):1401-9. PubMed ID: 23464534 [TBL] [Abstract][Full Text] [Related]
6. The impact of drug reimbursement policy on rates of testosterone replacement therapy among older men. Piszczek J; Mamdani M; Antoniou T; Juurlink DN; Gomes T PLoS One; 2014; 9(7):e98003. PubMed ID: 25029014 [TBL] [Abstract][Full Text] [Related]
7. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
8. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men. Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709 [TBL] [Abstract][Full Text] [Related]
9. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Borst SE; Yarrow JF Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953 [TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical Testosterone. Muram D; Kaltenboeck A; Boytsov N; Hayes-Larson E; Ivanova J; Birnbaum HG; Swindle R Am J Mens Health; 2015 Nov; 9(6):496-505. PubMed ID: 25271142 [TBL] [Abstract][Full Text] [Related]
11. Testosterone prescribing in men with depression and anxiety disorders. Javed Z; Kuo YF; Temple JR; Urban RJ; Holmes H; Baillargeon J Ann Epidemiol; 2020 Oct; 50():15-19.e8. PubMed ID: 32800673 [TBL] [Abstract][Full Text] [Related]
12. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy. Rhoden EL; Morgentaler A Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827 [TBL] [Abstract][Full Text] [Related]
13. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. Kovac JR; Rajanahally S; Smith RP; Coward RM; Lamb DJ; Lipshultz LI J Sex Med; 2014 Feb; 11(2):553-62. PubMed ID: 24344902 [TBL] [Abstract][Full Text] [Related]
14. Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations. Giagulli VA; Triggiani V; Corona G; Carbone D; Licchelli B; Tafaro E; Resta F; Sabbà C; Maggi M; Guastamacchia E Curr Pharm Des; 2011; 17(15):1500-11. PubMed ID: 21521164 [TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems. Bhatia R; Murphy AB; Raper JL; Chamie G; Kitahata MM; Drozd DR; Mayer K; Napravnik S; Moore R; Achenbach C; AIDS; 2015 Jan; 29(1):77-81. PubMed ID: 25387318 [TBL] [Abstract][Full Text] [Related]
16. Testosterone Replacement Therapy and Mortality in Older Men. Hackett GI Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385 [TBL] [Abstract][Full Text] [Related]
17. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency. Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244 [TBL] [Abstract][Full Text] [Related]
18. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307 [TBL] [Abstract][Full Text] [Related]
19. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. Grabner M; Hepp Z; Raval A; Tian F; Khera M J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664 [TBL] [Abstract][Full Text] [Related]
20. Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study. Mascarenhas A; Khan S; Sayal R; Knowles S; Gomes T; Moore JE Aging Male; 2016 Jun; 19(2):90-5. PubMed ID: 26927629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]